CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.1.1. Key benefits for stakeholders
1.1.2. Key market segments
1.2. RESEARCH METHODOLOGY
1.2.1. Secondary research
1.2.2. Primary research
1.2.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2015
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Rising focus on early diagnosis
3.4.1.2. Increasing geriatric population worldwide
3.4.1.3. Increasing burden of cardiology and neurological diseases
3.4.2. Restraints
3.4.2.1. Low biocompatibility of medical electrodes
3.4.3. Opportunities
3.4.3.1. Emerging nations - A great opportunity for medical electrodes manufacturers
3.5. GOVERNMENT REGULATIONS
3.5.1. FDA
3.5.2. Health Canada
3.5.3. CE Mark
3.5.4. Pharmaceuticals and Medical Devices Agency and Ministry of Health, Labor, and Welfare (MHLW)
3.5.5. Therapeutic Goods Administration (TGA)
CHAPTER 4 GLOBAL MEDICAL ELECTRODES MARKET, BY PRODUCT TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. SURFACE ELECTRODES
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.3. NEEDLE ELECTRODES
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
CHAPTER 5 MEDICAL ELECTRODES MARKET, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. CARDIOLOGY
5.2.1. Market size and forecast
5.2.2. Stress Test ECG
5.2.2.1. Market size and forecast
5.2.3. Neonatal ECG
5.2.3.1. Market size and forecast
5.2.4. Long-term monitoring ECG
5.2.4.1. Market size and forecast
5.2.5. Short-term monitoring EGG
5.2.5.1. Market size and forecast
5.2.6. Resting ECG
5.2.6.1. Market size and forecast
5.3. NEUROPHYSIOLOGY
5.3.1. Market size and forecast
5.4. ELECTROSURGERY
5.4.1. Market size and forecast
5.5. INTRA OPERATIVE MONITORING (IOM)
5.5.1. Market size and forecast
5.6. SLEEP STUDY
5.6.1. Market size and forecast
CHAPTER 6 GLOBAL MEDICAL ELECTRODES MARKET, BY MODALITY
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. MOTOR EVOKED POTENTIALS (MEPS)
6.2.1. Market size and forecast
6.3. SOMATOSENSORY EVOKED POTENTIALS (SSEPS)
6.3.1. Market size and forecast
6.4. ELECTROCARDIOGRAPHY (ECG)
6.4.1. Market size and forecast
6.5. ELECTROENCEPHALOGRAPHY (EEG)
6.5.1. Market size and forecast
6.6. ELECTROMYOGRAPHY (EMG)
6.6.1. Market size and forecast
6.7. BRAINSTEM AUDITORY EVOKED POTENTIALS (BAEPS)
6.7.1. Market size and forecast
6.8. VISUAL EVOKED POTENTIALS (VEPS)
6.8.1. Market size and forecast
CHAPTER 7 GLOBAL MEDICAL ELECTRODES DEVICES MARKET, BY REGION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S. market size and forecast
7.2.5. Canada market size and forecast
7.2.6. Mexico market size and forecast
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. France market size and forecast
7.3.5. Germany market size and forecast
7.3.6. UK market size and forecast
7.3.7. Italy market size and forecast
7.3.8. Spain market size and forecast
7.3.9. Netherlands market size and forecast
7.3.10. Norway market size and forecast
7.3.11. Russia market size and forecast
7.3.12. Sweden market size and forecast
7.3.13. Switzerland market size and forecast
7.3.14. Rest of the Europe market size and forecast
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Japan market size and forecast
7.4.5. China market size and forecast
7.4.6. India market size and forecast
7.4.7. Australia market size and forecast
7.4.8. South Korea market size and forecast
7.4.9. New Zealand market size and forecast
7.4.10. Taiwan market size and forecast
7.4.11. Thailand market size and forecast
7.4.12. Rest of Asia-Pacific market size and forecast
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Brazil market size and forecast
7.5.5. Saudi Arabia market size and forecast
7.5.6. South Africa market size and forecast
7.5.7. Chile market size and forecast
7.5.8. Columbia market size and forecast
7.5.9. Egypt market size and forecast
7.5.10. Iran market size and forecast
7.5.11. Israel market size and forecast
7.5.12. Turkey market size and forecast
7.5.13. Venezuela market size and forecast
7.5.14. Rest of LAMEA market size and forecast
CHAPTER 8 COMPANY PROFILE
8.1. 3M COMPANY
8.1.1. Company overview
8.1.2. Operating business segments
8.1.3. Business performance
8.1.4. Key strategic moves and developments
8.2. AMBU A/S
8.2.1. Company overview
8.2.2. Operating business segments
8.2.3. Business performance
8.2.4. Key strategic moves & developments
8.3. C. R. BARD, INC.
8.3.1. Company overview
8.3.2. Operating business segments
8.3.3. Business performance
8.3.4. Key strategic moves & developments
8.4. COGNIONICS INC.
8.4.1. Company overview
8.4.2. Operating business segments
8.4.3. Business performance
8.4.4. Key strategic moves & developments
8.5. CONMED CORPORATION
8.5.1. Company overview
8.5.2. Operating business segments
8.5.3. Business performance
8.5.4. Key strategic moves and developments
8.6. COOPER SURGICAL, INC.
8.6.1. Company overview
8.6.2. Operating business segments
8.6.3. Business performance
8.6.4. Key strategic moves and developments
8.7. DYMEDIX
8.7.1. Company overview
8.7.2. Operating business segments
8.7.3. Business performance
8.7.4. Key strategic moves & developments
8.8. KONINKLIJKE PHILIPS N.V.
8.8.1. Company overview
8.8.2. Operating business segments
8.8.3. Business performance
8.8.4. Key strategic moves & developments
8.9. MEDTRONIC PLC
8.9.1. Company overview
8.9.2. Operating business segments
8.9.3. Business performance
8.9.4. Key strategic moves & developments
8.10. NATUS MEDICAL INCORPORATED
8.10.1. Company overview
8.10.2. Business performance
8.10.3. Key strategic moves & developments
